Covered recipient · General Payments record
KYLE FRITZ OSTROM
Allopathic & Osteopathic Physicians Internal Medicine
General Payments · PY2018–2024
$1,710.21
- Reported across 88 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $306.63 | 19 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $248.68 | 15 |
| GlaxoSmithKline, LLC. | $28.61 | 2 |
| Amgen Inc. | $14.84 | 1 |
| SANOFI-AVENTIS U.S. LLC | $14.50 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (19)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $23.35 | 01/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105161923 | CMS |
| ABBVIE INC. | $33.14 | 01/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105161925 | CMS |
| ABBVIE INC. | $32.39 | 02/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105161927 | CMS |
| ABBVIE INC. | $25.63 | 03/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105161929 | CMS |
| ABBVIE INC. | $22.22 | 03/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105161931 | CMS |
| ABBVIE INC. | $8.15 | 03/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105161933 | CMS |
| ABBVIE INC. | $5.83 | 03/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105161935 | CMS |
| ABBVIE INC. | $15.75 | 03/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105161937 | CMS |
| ABBVIE INC. | $8.57 | 04/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105161939 | CMS |
| ABBVIE INC. | $15.06 | 05/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105161941 | CMS |
| ABBVIE INC. | $18.88 | 06/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105161943 | CMS |
| ABBVIE INC. | $7.19 | 07/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105161945 | CMS |
| ABBVIE INC. | $17.26 | 07/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105161947 | CMS |
| ABBVIE INC. | $8.42 | 10/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105161949 | CMS |
| ABBVIE INC. | $6.84 | 10/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105161951 | CMS |
| Amgen Inc. | $14.84 | 01/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117344700 | CMS |
| GlaxoSmithKline, LLC. | $14.60 | 02/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116646995 | CMS |
| GlaxoSmithKline, LLC. | $14.01 | 05/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116665197 | CMS |
| SANOFI-AVENTIS U.S. LLC | $14.50 | 12/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139767824 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.